Curaleaf Appoints Torsten Greif to Board of Directors

On May 1, 2026, Curaleaf Holdings, Inc., a prominent international cannabis provider, announced the appointment of Torsten Greif to their Board of Directors. Greif is respected as a founder of Four 20 Pharma GmbH, Curaleaf’s significant German brand. His expertise in cannabis cultivation and regulatory strategy has been key in positioning Four 20 Pharma as a leader in Germany's medical cannabis market.

Curaleaf’s CEO Boris Jordan highlighted Greif's strategic vision and local knowledge as vital assets for expanding Curaleaf’s European operations. Greif expressed honor at joining Curaleaf during its international expansion phase, emphasizing the rapidly evolving European cannabis market.

This appointment underscores Curaleaf’s commitment to strategic leadership as the company integrates its European presence and aims for long-term growth.